Search Results - H.X. Chen
- Showing 1 - 6 results of 6
-
1
-
2
-
3
Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma by Aung Naing, Patricia LoRusso, Siqing Fu, David S. Hong, H. X. Chen, L. Austin Doyle, Alexandria T. Phan, Mouhammed Amir Habra, Razelle Kurzrock
Published 2013Artigo -
4
-
5
Clinical relevance and functional implications for human leucocyte antigen‐g expression in non‐small‐cell lung cancer by Aifen Lin, Chengsong Zhu, H.‐X. Chen, B.‐F. Chen, X. Zhang, J.‐G. Zhang, Q. Wang, Wenchang Zhou, Wei‐Xin Hu, Haihua Yang, Heping Xu, Wei‐Hua Yan
Published 2009Artigo -
6
Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck by Athanassios Argiris, Athanasios Κotsakis, Tien Hoang, Francis P. Worden, P. Savvides, Michael K. Gibson, Rekha Gyanchandani, George R. Blumenschein, H.X. Chen, Jennifer R. Grandis, Paul M. Harari, M.S. Kies, S. Kim
Published 2012Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Biochemistry
Biology
Antigen
Clinical significance
Cytolysis
Engineering
Genetics
HLA-G
Human leukocyte antigen
Immunohistochemistry
Immunology
In vitro
Lung cancer
Oncology
Pathology
Adrenocortical carcinoma
Apoptosis
Bevacizumab
Cancer
Cancer research
Carcinoma
Cell
Cell culture
Cetuximab
Chemotherapy
Colorectal cancer
Computed tomography
Cytotoxic T cell